Chlamydophila pneumoniae Antibodies IgA (Serum)
The study is aimed at detecting IgA class antibodies to Chlamydophila pneumoniae — the pathogen of atypical respiratory tract infections.
Used for diagnosing active, prolonged, or persistent chlamydial infection of the respiratory tract.
Prescribed for prolonged cough, chronic bronchitis, pneumonia with sluggish, prolonged, or recurring course.
Applied when chronic inflammatory respiratory diseases not responding to standard therapy are suspected.
Allows assessment of Chlamydophila pneumoniae's involvement in the formation of a chronic infectious process.
What the test assesses:
– Presence or absence of IgA class antibodies to Chlamydophila pneumoniae.
– Activity of the infectious process.
– State of local (mucosal) immune response of the respiratory tract.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Drinking still water is allowed.
– It is recommended to avoid physical exertion and stress before blood collection.
Medications:
– It is advisable to submit the test before starting antibacterial therapy.
– Immunomodulator and immunoglobulin intake may affect IgA antibody levels.
– When taking any medications, it is necessary to inform the doctor or indicate the information when submitting the test.
Recommended for testing:
– With prolonged respiratory symptoms, persistent cough, low-grade fever.
– With chronic bronchitis, atypical or recurring pneumonia.
– When chronic or persistent chlamydial infection is suspected.
– With frequent and prolonged URI, bronchitis, and pneumonia in children.
– Positive result (IgA detected): indicates activity or persistence of infection, often characteristic of chronic or prolonged disease course.
– Negative result (IgA not detected): active process is unlikely; past infection or early disease stage is possible.
Important — for accurate clinical assessment, comprehensive examination of IgA + IgG + IgM and/or PCR diagnostics is recommended.
